{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:39:58Z","timestamp":1772771998392,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Medicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.imj.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T04:08:29Z","timestamp":1682654909000},"page":"202-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes"],"prefix":"10.1016","volume":"2","author":[{"given":"Andrea","family":"Piccioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8638-7565","authenticated-orcid":false,"given":"Laura","family":"Franza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8443-7880","authenticated-orcid":false,"given":"Marcello","family":"Candelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Covino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3178-0797","authenticated-orcid":false,"given":"Gianpietro","family":"Volonnino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Bertozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Vittoria Zamponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniello","family":"Maiese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Savioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"La Russa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pcd.2020.05.014","article-title":"Beyond the virus: ensuring continuity of care for people with diabetes during COVID-19","volume":"15","author":"Beran","year":"2021","journal-title":"Prim. Care Diabetes"},{"issue":"3","key":"10.1016\/j.imj.2023.04.006_bib0002","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/ejcts\/ezab314","article-title":"Corrigendum to 'Impact of the coronavirus disease 2019 (COVID-19) pandemic on the care of patients with acute and chronic aortic conditions'","volume":"60","author":"Czerny","year":"2021","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"2","key":"10.1016\/j.imj.2023.04.006_bib0003","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jhep.2020.04.005","article-title":"The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care","volume":"73","author":"Tapper","year":"2020","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.imj.2023.04.006_bib0004","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ajcp\/aqaa106","article-title":"Frontline workers in the backrooms of COVID-19","volume":"154","author":"Myers","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"issue":"9","key":"10.1016\/j.imj.2023.04.006_bib0005","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/ene.14375","article-title":"Stroke care during the COVID-19 pandemic: experience from three large European countries","volume":"27","author":"Bersano","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.imj.2023.04.006_bib0006","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.carrev.2020.05.027","article-title":"Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemic","volume":"21","author":"Yerasi","year":"2020","journal-title":"Cardiovasc. Revasc. Med."},{"issue":"22","key":"10.1016\/j.imj.2023.04.006_bib0007","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehaa409","article-title":"Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era","volume":"41","author":"De Rosa","year":"2020","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.imj.2023.04.006_bib0008","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1152\/physiolgenomics.00089.2020","article-title":"The COVID-19 pandemic: a global health crisis","volume":"52","author":"Pollard","year":"2020","journal-title":"Physiol. Genom."},{"issue":"8","key":"10.1016\/j.imj.2023.04.006_bib0009","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.imj.2023.04.006_bib0010","series-title":"StatPearls [Internet]","article-title":"Systemic inflammatory response syndrome","author":"Chakraborty","year":"2023"},{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ddr.21720","article-title":"Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19","volume":"82","author":"Rohilla","year":"2021","journal-title":"Drug Dev. Res."},{"issue":"11","key":"10.1016\/j.imj.2023.04.006_bib0012","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"issue":"8","key":"10.1016\/j.imj.2023.04.006_bib0013","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/medicina57080770","article-title":"Presepsin as early marker of sepsis in emergency department: a narrative review","volume":"57","author":"Piccioni","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.imj.2023.04.006_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108651","article-title":"Interrelations between COVID-19 and other disorders","volume":"224","author":"Gasmi","year":"2021","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.imj.2023.04.006_bib0015","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.5858\/arpa.2020-0471-SA","article-title":"Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers","volume":"144","author":"Tjendra","year":"2020","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.imj.2023.04.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/2058738419855226","article-title":"Searching for highly sensitive and specific biomarkers for sepsis: state-of-the-art in post-mortem diagnosis of sepsis through immunohistochemical analysis","volume":"33","author":"La Russa","year":"2019","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.imj.2023.04.006_bib0017","article-title":"Wound vitality in decomposed bodies: new frontiers through immunohistochemistry","volume":"8","author":"Bertozzi","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"3","key":"10.1016\/j.imj.2023.04.006_bib0018","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5152\/TJAR.2017.93753","article-title":"Changing definitions of sepsis","volume":"45","author":"G\u00fcl","year":"2017","journal-title":"Turk. J. Anaesthesiol. Reanim."},{"issue":"9","key":"10.1016\/j.imj.2023.04.006_bib0019","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/medicina57090920","article-title":"Proadrenomedullin in sepsis and septic shock: a role in the emergency department","volume":"57","author":"Piccioni","year":"2021","journal-title":"Medicina (Kaunas)."},{"key":"10.1016\/j.imj.2023.04.006_bib0020","unstructured":"CDC. What is sepsis? Avaliable on: https:\/\/www.cdc.gov\/sepsis\/what-is-sepsis.html. (accessed on 9 October 2022)."},{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0021","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/ijms22010321","article-title":"MicroRNAs and sepsis-induced cardiac dysfunction: a systematic review","volume":"22","author":"Manetti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.imj.2023.04.006_bib0022","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0025817220926915","article-title":"Thromboinflammatory response in SARS-CoV-2 sepsis","volume":"88","author":"Maiese","year":"2020","journal-title":"Med. Leg. J."},{"issue":"6","key":"10.1016\/j.imj.2023.04.006_bib0023","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/medicina57060638","article-title":"Neutropenic enterocolitis and sepsis: towards the definition of a pathologic profile","volume":"57","author":"Bertozzi","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.imj.2023.04.006_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/2058738418776526","article-title":"Septic cardiomyopathy: the value of lactoferrin and CD15 as specific markers to corroborate a definitive diagnosis","volume":"32","author":"Galassi","year":"2018","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13049-019-0609-3","article-title":"Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with sepsis","volume":"27","author":"Liu","year":"2019","journal-title":"Scand. J. Trauma Resusc. Emerg. Med."},{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0026","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019 - results from a systematic review and meta-analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0027","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13054-018-2157-z","article-title":"The global burden of sepsis: barriers and potential solutions","volume":"22","author":"Rudd","year":"2018","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.imj.2023.04.006_bib0028","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"8","key":"10.1016\/j.imj.2023.04.006_bib0029","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imj.2023.04.006_bib0030","unstructured":"University J.H. 2023. SARS-COV-2 Data in Motion. Avaliable on: https:\/\/coronavirus.jhu.edu\/. (accessed on 9 October 2022)."},{"key":"10.1016\/j.imj.2023.04.006_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.582932","article-title":"Coronavirus disease (COVID-19): comprehensive review of clinical presentation","volume":"8","author":"Mehta","year":"2021","journal-title":"Front. Public Health"},{"issue":"12","key":"10.1016\/j.imj.2023.04.006_bib0032","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/ajmg.a.61867","article-title":"Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy - a case series","volume":"182","author":"Villani","year":"2020","journal-title":"Am. J. Med. Genet. A"},{"issue":"11","key":"10.1016\/j.imj.2023.04.006_bib0033","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s00415-020-09990-2","article-title":"Neurological involvement of coronavirus disease 2019: a systematic review","volume":"267","author":"Ghannam","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.imj.2023.04.006_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2020.113426","article-title":"How and why patients made long Covid","volume":"268","author":"Callard","year":"2021","journal-title":"Soc. Sci. Med."},{"issue":"5","key":"10.1016\/j.imj.2023.04.006_bib0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10408363.2020.1860895","article-title":"COVID-19: from an acute to chronic disease? Potential long-term health consequences","volume":"58","author":"Higgins","year":"2021","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0036","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7196\/SAMJ.2020.v111i11.15433","article-title":"Long-COVID: an evolving problem with an extensive impact","volume":"111","author":"Mendelson","year":"2020","journal-title":"S. Afr. Med. J."},{"issue":"5","key":"10.1016\/j.imj.2023.04.006_bib0037","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3949\/ccjm.88a.21010","article-title":"Post-acute sequelae of SARS-CoV-2 infection: caring for the 'long-haulers'","volume":"88","author":"Vehar","year":"2021","journal-title":"Cleveland Clin. J. Med."},{"key":"10.1016\/j.imj.2023.04.006_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.549692","article-title":"Are lockdown measures effective against COVID-19?","volume":"8","author":"Kharroubi","year":"2020","journal-title":"Front. Public Health"},{"issue":"11","key":"10.1016\/j.imj.2023.04.006_bib0039","doi-asserted-by":"crossref","first-page":"e22287","DOI":"10.2196\/22287","article-title":"The COVID-19 pandemic: a pandemic of lockdown loneliness and the role of digital technology","volume":"22","author":"Shah","year":"2020","journal-title":"J. Med. Internet Res."},{"issue":"7","key":"10.1016\/j.imj.2023.04.006_bib0040","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s40520-020-01601-4","article-title":"The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing","volume":"32","author":"Palmer","year":"2020","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.imj.2023.04.006_bib0041","unstructured":"Eduardo Levy Yeyati, F.F. 2023 Pandemic divergence: the social and economic costs of SARS-CoV-2. Avaliable on: https:\/\/voxeu.org\/article\/social-and-economic-costs-SARS-CoV-2. (accessed on 9 October 2022)."},{"issue":"6","key":"10.1016\/j.imj.2023.04.006_bib0042","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1017\/S0033291720001841","article-title":"Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy","volume":"51","author":"Iasevoli","year":"2021","journal-title":"Psychol. Med."},{"issue":"27","key":"10.1016\/j.imj.2023.04.006_bib0043","doi-asserted-by":"crossref","first-page":"15530","DOI":"10.1073\/pnas.2007658117","article-title":"Economic and social consequences of human mobility restrictions under COVID-19","volume":"117","author":"Bonaccorsi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.imj.2023.04.006_bib0044","unstructured":"Sanit\u00e0, I.S.d. 2023 SARS-COV-2. Avaliable on: https:\/\/www.epicentro.iss.it\/. (accessed on 9 October 2022)."},{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.arcmed.2020.09.010","article-title":"Coronavirus disease (COVID-19): current status and prospects for drug and vaccine development","volume":"52","author":"Ita","year":"2021","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.imj.2023.04.006_bib0046","unstructured":"AIFA 2023 Vaccini SARS-COV-2. Avaliable on: https:\/\/www.aifa.gov.it\/vaccini-SARS-CoV-2. (accessed on 9 October 2022)."},{"key":"10.1016\/j.imj.2023.04.006_bib0047","unstructured":"AIFA 2023 Report vaccini anti SARS-COV-2. Avaliable on: https:\/\/www.governo.it\/it\/cscovid19\/report-vaccini\/. (accessed on 9 October 2022)."},{"key":"10.1016\/j.imj.2023.04.006_bib0048","unstructured":"Erlanger, S. 2023 \u2018Vaccinated, Recovered or Dead\u2019: Europe Fights Covid Wave\u2014and Itself. Avaliable on: https:\/\/www.nytimes.com\/2021\/11\/22\/world\/europe\/covid-europe-surge-protests.html. (accessed on 9 October 2022)."},{"issue":"2","key":"10.1016\/j.imj.2023.04.006_bib0049","doi-asserted-by":"crossref","first-page":"327","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"8","key":"10.1016\/j.imj.2023.04.006_bib0050","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.imj.2023.04.006_bib0051","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/ijerph18031268","article-title":"Risk management and treatment of coagulation disorders related to COVID-19 infection","volume":"18","author":"Zanza","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"14","key":"10.1016\/j.imj.2023.04.006_bib0052","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.7150\/ijbs.48400","article-title":"Immune response and COVID-19: a mirror image of sepsis","volume":"16","author":"L\u00f3pez-Collazo","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.imj.2023.04.006_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J. Clin. Virol."},{"issue":"10229","key":"10.1016\/j.imj.2023.04.006_bib0054","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.imj.2023.04.006_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2021.03.002","article-title":"COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?","volume":"232","author":"Ombrello","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.imj.2023.04.006_bib0056","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imj.2023.04.006_bib0057","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.imj.2023.04.006_bib0058","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3390\/biomedicines9091234","article-title":"Microbiota and myopericarditis: the new frontier in the car-diological field to prevent or treat inflammatory cardiomyo-pathies in COVID-19 outbreak","volume":"9","author":"Piccioni","year":"2021","journal-title":"Biomedicines"},{"issue":"21","key":"10.1016\/j.imj.2023.04.006_bib0059","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.3390\/ijms20215376","article-title":"The pathogenesis of sepsis and potential therapeutic targets","volume":"20","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.imj.2023.04.006_bib0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.33549\/physiolres.934492","article-title":"COVID-19 and the immune system","volume":"69","author":"Paces","year":"2020","journal-title":"Physiol. Res."},{"issue":"7562","key":"10.1016\/j.imj.2023.04.006_bib0061","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","article-title":"T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection","volume":"523","author":"McKinney","year":"2015","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.imj.2023.04.006_bib0062","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.3390\/ijms21155238","article-title":"Interleukin-6 in rheumatoid arthritis","volume":"21","author":"Pandolfi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.imj.2023.04.006_bib0063","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0064","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMc2032911","article-title":"Tocilizumab in Covid-19","volume":"384","author":"Leaf","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.imj.2023.04.006_bib0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/medicina58020144","article-title":"Cytokine storm in COVID-19: immunopathogenesis and therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0066","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pulmoe.2020.07.003","article-title":"Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review","volume":"27","author":"Cortegiani","year":"2021","journal-title":"Pulmonology"},{"key":"10.1016\/j.imj.2023.04.006_bib0067","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijid.2020.06.099","article-title":"Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19","volume":"97","author":"Arshad","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.imj.2023.04.006_bib0068","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1007\/s11606-020-06146-w","article-title":"Chloroquine and hydroxychloroquine for the treatment of SARS-COV-2: a systematic review and meta-analysis","volume":"35","author":"Elavarasi","year":"2020","journal-title":"J. Gen. Intern. Med."},{"issue":"13","key":"10.1016\/j.imj.2023.04.006_bib0069","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","article-title":"Pharmaco-immunomodulatory therapy in COVID-19","volume":"80","author":"Rizk","year":"2020","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.imj.2023.04.006_bib0070","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/eji.202048693","article-title":"Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity","volume":"50","author":"Schijns","year":"2020","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.imj.2023.04.006_bib0071","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40264-020-00976-7","article-title":"Azithromycin in COVID-19 patients: pharmacological mechanism, clinical evidence and prescribing guidelines","volume":"43","author":"Sultana","year":"2020","journal-title":"Drug Saf."},{"key":"10.1016\/j.imj.2023.04.006_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antiviral Res."},{"issue":"13","key":"10.1016\/j.imj.2023.04.006_bib0073","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.imj.2023.04.006_bib0074","article-title":"Corticosteroids for treating sepsis","volume":"2015","author":"Annane","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.imj.2023.04.006_bib0075","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/vaccines10020216","article-title":"SARS-CoV2 vaccination adverse events trend in Italy: a retrospective interpretation of the last year (December 2020-September 2021)","volume":"10","author":"Fazio","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"42","key":"10.1016\/j.imj.2023.04.006_bib0076","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.2174\/0929867325666180518072730","article-title":"The importance of complying with vaccination protocols in developed countries: \u201canti-vax\u201d hysteria and the spread of severe preventable diseases","volume":"25","author":"Pandolfi","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.imj.2023.04.006_bib0077","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/CCM.0000000000002262","article-title":"Increased time to initial antimicrobial administration is associated with progression to septic shock in severe sepsis patients","volume":"45","author":"Whiles","year":"2017","journal-title":"Crit. Care Med."},{"issue":"10219","key":"10.1016\/j.imj.2023.04.006_bib0078","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.imj.2023.04.006_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.602848","article-title":"Parallels in sepsis and COVID-19 conditions: implications for managing severe COVID-19","volume":"12","author":"Olwal","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imj.2023.04.006_bib0080","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.chest.2020.07.023","article-title":"Coronavirus disease 2019 sepsis: a nudge toward antibiotic stewardship","volume":"158","author":"Coz Yataco","year":"2020","journal-title":"Chest"},{"issue":"10235","key":"10.1016\/j.imj.2023.04.006_bib0081","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.imj.2023.04.006_bib0082","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3389\/fphys.2020.00747","article-title":"COVID-19 sepsis and microcirculation dysfunction","volume":"11","author":"Colantuoni","year":"2020","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.imj.2023.04.006_bib0083","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/microorganisms9010159","article-title":"Severe COVID-19 and sepsis: immune pathogenesis and laboratory markers","volume":"9","author":"Zafer","year":"2021","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.imj.2023.04.006_bib0084","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/ACO.0000000000000163","article-title":"The coagulopathy of acute sepsis","volume":"28","author":"Simmons","year":"2015","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.imj.2023.04.006_bib0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jgar.2020.10.004","article-title":"Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: an alarming \u201ccollateral effect\u201d","volume":"23","author":"Cataldo","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.imj.2023.04.006_bib0086","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11739-021-02807-8","article-title":"Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment","volume":"17","author":"Rossio","year":"2022","journal-title":"Intern. Emerg. Med."},{"issue":"8","key":"10.1016\/j.imj.2023.04.006_bib0087","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1007\/s00134-020-06106-2","article-title":"Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis","volume":"46","author":"Markwart","year":"2020","journal-title":"Intensive Care Med."},{"issue":"8","key":"10.1016\/j.imj.2023.04.006_bib0088","doi-asserted-by":"crossref","first-page":"329","DOI":"10.37765\/ajmc.2020.43838","article-title":"Chronic disease management in the COVID-19 era","volume":"26","author":"Mirsky","year":"2020","journal-title":"Am. J. Manag. Care"},{"issue":"8","key":"10.1016\/j.imj.2023.04.006_bib0089","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2174\/1389201020666190408102221","article-title":"Medical records quality as prevention tool for healthcare-associated infections (HAIs) related litigation: a case series","volume":"20","author":"Albano","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"4","key":"10.1016\/j.imj.2023.04.006_bib0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cjtee.2020.06.002","article-title":"The severe COVID-19: a sepsis induced by viral infection? And its immunomodulatory therapy","volume":"23","author":"Lin","year":"2020","journal-title":"Chin. J. Traumatol."},{"key":"10.1016\/j.imj.2023.04.006_bib0092","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.558898","article-title":"COVID-19: in the eye of the cytokine storm","volume":"11","author":"de la Rica","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Infectious Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X23000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X23000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T23:42:58Z","timestamp":1767397378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772431X23000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2772431X23000254"],"URL":"https:\/\/doi.org\/10.1016\/j.imj.2023.04.006","relation":{},"ISSN":["2772-431X"],"issn-type":[{"value":"2772-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes","name":"articletitle","label":"Article Title"},{"value":"Infectious Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imj.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}]}}